Acumen Pharmaceuticals, Inc.
ABOS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001576885
No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Acumen Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 62 | 53 | −9 |
| Shares | 27.8M | 26.3M | −1.43M (−5.1%) |
| Value | $112.8M | $126.6M | +$13.9M (+12.3%) |
New holders (9)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Catalyst Financial Partners LLC | 89,699 | $431.5K | 0.15% |
| Prelude Capital Management, LLC | 31,100 | $149.6K | 0.01% |
| Balyasny Asset Management LLC | 30,222 | $145.4K | 0.00% |
| Pinnacle Associates Ltd | 18,020 | $86.7K | 0.00% |
| Pinnacle Wealth Management Advisory Group, LLC | 18,020 | $86.7K | 0.01% |
| Belvedere Trading LLC | 12,931 | $62.2K | 0.02% |
| BIT Capital GmbH | 11,618 | $55.9K | 0.01% |
| Simplex Trading, LLC | 4,546 | $21.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 892 | $4.29K | 0.00% |
Sold out (18)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Driehaus Capital Management LLC | 550,349 | $2.23M |
| Woodline Partners LP | 426,172 | $1.73M |
| Commodore Capital LP | 400,000 | $1.62M |
| Walleye Capital LLC | 196,539 | $797.9K |
| Silverarc Capital Management, LLC | 146,922 | $596.5K |
| Guardian Point Capital, LP | 130,000 | $527.8K |
| Susquehanna International Group, LLP | 129,794 | $527.0K |
| Jane Street Group, LLC | 74,541 | $302.6K |
| Atom Investors LP | 62,952 | $255.6K |
| Qube Research & Technologies Ltd | 44,385 | $180.2K |
| HRT Financial LP | 43,115 | $175.0K |
| 683 Capital Management, LLC | 31,246 | $126.9K |
| Man Group plc | – | $104.5K |
| Chicago Partners Investment Group LLC | 12,332 | $46.6K |
| Jump Financial, LLC | 10,183 | $41.3K |
| Point72 Asset Management, L.P. | 3,954 | $16.1K |
| Point72 Middle East FZE | 3,415 | $13.9K |
| UBS Group AG | 3,137 | $12.7K |